Telehealth ADHD Prescribing: What Psychiatric NPs Can Do in Texas

If you’re a psychiatrist or PMHNP wondering whether you can legally prescribe Adderall, Vyvanse, or other ADHD medications through telehealth — the short answer is yes, you can right now. But there’s a critical ‘for now’ attached to that answer.

The pandemic-era federal flexibilities that allowed providers to prescribe Schedule II stimulants via telemedicine without an initial in-person exam have been extended through December 31, 2025. As we move into 2026, the future of telehealth ADHD prescribing sits in regulatory limbo. Unless Congress or the DEA acts, we could see a return to the pre-COVID requirement of in-person exams before writing that first Adderall script.

For psychiatrists building or scaling an ADHD practice, this uncertainty matters. But so does the reality on the ground: patient demand for ADHD treatment is at an all-time high, telehealth has proven effective for medication management, and reimbursement parity is nearly universal. Let’s break down what psychiatrists can actually do right now, what’s coming, and how to build a compliant, profitable telehealth ADHD practice in 2026.

The Federal Framework: Where We Stand on Telehealth Controlled Substance Prescribing

The Ryan Haight Act and COVID Waivers

Before 2020, federal law (the Ryan Haight Act of 2008) required at least one in-person medical evaluation before a provider could prescribe any Schedule II controlled substance via telemedicine. For ADHD treatment, this meant you couldn’t start a patient on Adderall through a video visit alone.

The COVID-19 Public Health Emergency changed everything. The DEA issued temporary waivers allowing providers to prescribe stimulants entirely via telehealth, provided they conducted a proper audio-visual evaluation and met standard-of-care requirements. This flexibility was a game-changer for access — suddenly, patients in psychiatrist deserts could get ADHD care from providers hundreds of miles away.

Where We Are Now (Early 2026)

The DEA and HHS have extended these telehealth prescribing flexibilities three times. The most recent extension pushed the deadline to the end of 2025. As of February 2026, we’re in a holding pattern. Psychiatrists can still prescribe stimulants to new patients via telehealth under the extended waiver, but the regulatory clock is ticking.

What happens next? Three possible scenarios:

1. Congressional action: A permanent telehealth prescribing law passes (several bills have been proposed but not enacted)
2. DEA rulemaking: The DEA finalizes a ‘special registration’ pathway for telemedicine prescribing of controlled substances (proposed but not implemented)
3. Reversion to pre-COVID rules: If nothing passes, the Ryan Haight Act’s in-person requirement returns, meaning new ADHD patients would need at least one face-to-face visit before you could prescribe stimulants

For now, you can continue practicing as you have been. But smart psychiatrists are preparing contingency plans — partnerships with local clinics for in-person evaluations, protocols for non-stimulant alternatives during initial treatment, or hybrid models that build in an early in-person visit.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

What Psychiatrists Can Do: Full Authority, Zero Supervision Required

Here’s what sets psychiatrists apart in the ADHD prescribing landscape: you have complete prescriptive authority in every state, with no supervision requirement, for all ADHD medications.

Clinical Capabilities via Telehealth

ADHD diagnosis and medication management translate remarkably well to telemedicine. The bulk of ADHD evaluation is based on:

• Clinical interview: Detailed history of symptoms, onset, impact on functioning — easily done via video
• Standardized rating scales: ADHD RS-IV, ASRS for adults, Conners for children — all can be administered electronically
• Collateral information: Teacher reports, partner observations, prior records — obtained digitally
• Mental status exam: Observation of attention, impulse control, restlessness — visible on video

The physical exam requirements for ADHD are minimal. Since stimulants can affect blood pressure and heart rate, best practice includes baseline vitals. In telehealth, you can:

• Ask patients to obtain vitals at a pharmacy or primary care visit
• Recommend they purchase a home BP cuff (many patients already have them)
• Coordinate with their PCP for a brief in-person check if needed

What you can’t do via pure telehealth: hands-on cardiac exam, administer injections, or anything requiring physical presence. But since ADHD medications are all oral and the condition doesn’t require procedures, there are effectively no clinical limitations to managing ADHD via telemedicine as a psychiatrist.

Prescriptive Authority

Psychiatrists can prescribe:

• Schedule II stimulants: Adderall (amphetamine salts), Vyvanse (lisdexamfetamine), Ritalin/Concerta (methylphenidate), Dexedrine
• Non-stimulants: Strattera (atomoxetine), Qelbree (viloxazine), Intuniv (guanfacine), Kapvay (clonidine)
• Off-label medications: Bupropion (Wellbutrin), modafinil, or other adjuncts based on clinical judgment

You write the prescription, e-prescribe it through a DEA-compliant platform, and it goes directly to the patient’s pharmacy. No countersignature needed, no physician oversight required, no quantity limits beyond standard DEA regulations (typically 30-day supplies for Schedule II, with the option to write sequential prescriptions for up to 90 days).

This is very different from what NPs face in many states (more on that below), and it’s a key reason psychiatrists remain in high demand for ADHD telehealth platforms.

State-Specific Considerations: Telehealth Rules and NP Restrictions

While federal law sets the baseline for controlled substance prescribing, state laws add another layer. Here’s what psychiatrists need to know about telehealth ADHD prescribing in the six highest-demand states:

Florida: Explicitly Permits Telehealth Stimulant Prescribing for Psychiatric Disorders

Florida law actually encourages telehealth ADHD care. Florida Statute 456.47 generally prohibits prescribing Schedule II controlled substances via telehealth, except when the medication is prescribed for specific conditions — including psychiatric disorders.

ADHD qualifies. This means a Florida-licensed psychiatrist can legally prescribe Adderall through a video visit for an ADHD patient without any additional in-person requirement beyond federal law. Florida carved out this exception specifically to preserve access to mental health treatment via telehealth while restricting opioid prescribing for chronic pain.

What Florida psychiatrists must do:

• Check the state’s E-FORCSE prescription monitoring database before prescribing controlled substances (required for all Schedule II-IV drugs)
• Use e-prescribing (Florida mandated EPCS for controlled substances starting 2021)
• Document that the prescription is for a psychiatric disorder (ADHD diagnosis in chart)
• Maintain standard of care equivalent to in-person treatment

Florida’s psychiatrist shortage (1 per ~8,600 residents) makes telehealth critical for access, and the state legislature recognized this in its telehealth law.

Texas: Telehealth Mental Health Prescribing Allowed, But NPs Are Severely Limited

Texas permits psychiatrists to prescribe controlled substances via telehealth for mental health treatment, as long as the encounter uses live audio-visual communication (video required, not just phone). Texas explicitly prohibits telehealth controlled substance prescribing for chronic pain management, but ADHD doesn’t fall under that restriction.

The Texas NP constraint: Texas law forbids Nurse Practitioners from prescribing Schedule II drugs in outpatient settings except in hospitals, emergency departments, or hospice. This means only psychiatrists (and other MDs) can prescribe Adderall for routine outpatient ADHD patients in Texas. Even with a collaborative agreement, a Texas PMHNP cannot write that prescription.

For telehealth platforms operating in Texas, this creates massive demand for psychiatrists. With one of the worst psychiatrist-to-population ratios in the country (1:9,000+) and 185 of 254 counties designated as mental health shortage areas, Texas ADHD patients often wait months for appointments. Psychiatrists licensed in Texas can build full caseloads quickly.

Texas compliance requirements:

• Use synchronous video (audio-only prohibited for controlled substances except very limited exceptions)
• Follow standard of care (Texas emphasizes that telehealth must meet the same diagnostic and treatment standards as in-person)
• Be prepared for potential scrutiny — Texas legislators have raised concerns about online platforms over-prescribing stimulants, so documentation and appropriate prescribing are critical

California: Transitioning to Greater NP Independence, But Still Physician-Led

California is phasing in Nurse Practitioner independence through AB 890. Experienced NPs (3+ years, 4,600+ hours) can apply for independent practice status, but until they achieve that, they need physician supervision. Even independent NPs must complete a specialized pharmacology course to prescribe Schedule II medications.

For psychiatrists, this means:

• You can practice completely independently — no restrictions on telehealth ADHD prescribing beyond federal law
• High demand in underserved areas (Central Valley, Inland Empire, rural Northern California) despite the state’s overall higher provider density
• E-prescribing mandatory (California requires EPCS for all controlled substances since 2022)

California’s large, tech-savvy population drives high demand for adult ADHD treatment, particularly in metro areas like San Francisco and LA where awareness and acceptance of ADHD diagnosis is high.

New York: NP Independence After Experience, Strong Telehealth Support

New York allows NPs to achieve full practice authority after 3,600 hours (~2 years) of supervised practice. After that, they can prescribe stimulants independently, with no physician oversight required.

For psychiatrists in NY:

• Full independent authority from day one (unlike NPs who need the supervised period)
• Mandatory PDMP check before every controlled substance prescription (New York’s I-STOP program is strictly enforced)
• E-prescribing required for all prescriptions including controlled substances
• Strong telehealth reimbursement parity (both Medicaid and commercial insurers pay equivalent to in-person)

New York has one of the best psychiatrist-to-population ratios (1:2,900), but distribution is uneven — NYC is saturated while upstate rural areas are shortage zones. Telehealth allows NYC-based psychiatrists to serve patients across the state.

Pennsylvania: NP Collaborative Requirements and Quantity Limits

Pennsylvania requires all NPs to have collaborative agreements with physicians. For Schedule II prescribing, PA imposes a 72-hour initial supply limit for new patients or new conditions. After that, NPs can prescribe 30-day supplies but the patient must be re-evaluated by the supervising physician before extended treatment.

What this means for psychiatrists:

• You’re essential in PA because NPs can’t initiate ADHD stimulant treatment smoothly without MD involvement
• No quantity limits for physicians — you can prescribe standard 30-day supplies from the start
• Collaborative practices often have the psychiatrist handle initial ADHD evaluations and prescriptions, with NPs managing follow-ups

Pennsylvania’s moderate psychiatrist density (1:4,600) masks urban/rural disparities. Philadelphia and Pittsburgh have adequate supply; rural central and northern PA counties face shortages.

Illinois: Emerging NP Independence, Strong Telehealth Parity

Illinois allows NPs to obtain Full Practice Authority after 4,000 hours of clinical experience plus additional training. Once granted FPA, Illinois PMHNPs can prescribe ADHD medications independently (though they need physician consultation for Schedule II opioids, this doesn’t apply to stimulants).

For psychiatrists:

• Full authority as always
• Opportunity to collaborate with NPs during their required experience period (one physician can collaborate with up to 5 NPs)
• E-prescribing mandatory (Illinois required EPCS for controlled substances starting January 2023)
• Strong telehealth reimbursement support (Illinois passed comprehensive telehealth parity in 2021)

Illinois’s psychiatrist shortage is concentrated in downstate rural areas, while Chicago has relatively good supply. Telehealth ADHD services can tap into unmet need across the state.

PMHNP vs Psychiatrist Prescribing Authority: Why It Matters for ADHD Care

The difference between psychiatrist and PMHNP prescribing authority isn’t about clinical competence — it’s entirely about legal scope of practice, which varies dramatically by state.

Where PMHNPs Have Full ADHD Prescribing Authority:

• New York (after 3,600 supervised hours)
• Illinois (with Full Practice Authority after 4,000 hours)
• California (independent NPs with Schedule II pharmacology certification)
• About 25 other states with full practice authority

Where PMHNPs Are Restricted or Prohibited from ADHD Stimulant Prescribing:

• Texas: Cannot prescribe Schedule II outpatient (physician only)
• Florida: Require psychiatrist collaboration; limited to 7-day supplies unless classified as ‘psychiatric nurse’ under psychiatrist protocol
• Pennsylvania: Can prescribe only 72-hour initial supply; need physician re-evaluation before continuation
• Georgia: Cannot prescribe Schedule II at all
• Several other states with varying restrictions

Why this matters for telehealth platforms:

If you’re a psychiatrist considering joining a platform like Klarity, understand that in restrictive states, you’re not competing with NPs — you’re the only option for stimulant prescribing. This increases your leverage and ensures patient volume.

If you’re a PMHNP, know your state’s rules before accepting telehealth patients. Some platforms handle collaborative agreements for you in restricted states; others only allow NPs to practice in states where they have full authority. You may need to get licensed in multiple states to build a full caseload, favoring FPA states like New York, Illinois, and (increasingly) California.

Reimbursement: What Psychiatrists Actually Get Paid for Telehealth ADHD Care

Telehealth Payment Parity Is Nearly Universal in 2026

After years of advocacy and post-pandemic policy shifts, approximately 48 states now have some form of telehealth payment parity — either through statute or widespread insurer adoption. This means commercial insurers and Medicaid programs pay the same rate for a virtual ADHD medication management visit as they would for in-person.

Medicare has extended telehealth coverage for mental health services, treating tele-mental visits at non-facility rates (full reimbursement, not reduced). Congress has shown strong support for making these flexibilities permanent.

Typical Reimbursement Rates for Medication Management (2026 Data):

What this means in practice:

A psychiatrist conducting four 15-minute medication follow-ups per hour via telehealth, billing 99213 at Medicare rates, generates approximately $360/hour gross from Medicare (likely $400-500+/hour from commercial payers). If those are new patient intakes (90792), you’re looking at $750+/hour.

Compare this to in-person practice where you need to factor in:

• Office rent and overhead
• Commute time between home and office
• Patient no-shows (higher in-person than virtual)
• Geographic constraints on patient volume

Telehealth economics for ADHD medication management are compelling: low overhead, high patient demand, schedule flexibility, and equivalent reimbursement to in-person.

Psychiatrists Get Paid More Than Other Providers

Medicare and most commercial insurers reimburse psychiatrists (MD/DO) at higher rates than NPs or PAs for the same services. NPs typically get 85% of the physician rate if billing under their own NPI (many practices use ‘incident-to’ billing to get full rates, but this is complex and often doesn’t work in telehealth).

For medication management specifically, having an MD credential means you’re at the top of the reimbursement hierarchy for mental health services. Combined with full prescriptive authority and no supervision requirements, psychiatrists have a clear economic advantage in the ADHD treatment market.

The Economics of Telehealth ADHD Practice: Patient Acquisition and Platform Models

Let’s address the elephant in the room: patient acquisition costs.

The DIY Marketing Reality

Many psychiatrists starting a private practice consider building their own patient base through:

• SEO and website optimization
• Google Ads for local searches (‘ADHD psychiatrist near me’)
• Directory listings (Psychology Today, Zocdoc, Healthgrades)
• Social media marketing

Here’s what that actually costs when you factor in all expenses:

That doesn’t include:

• Your time managing campaigns and responding to leads
• Staff time to answer phones and qualify patients
• No-show rates (cold leads from ads have higher no-show rates than warm referrals)
• Failed campaigns and wasted ad spend during testing

The real cost of acquiring a qualified ADHD patient through DIY marketing is $200-500+, and it requires months of consistent investment before you see results. Most solo practitioners don’t have the marketing expertise or patience to execute effectively.

The Platform Economics Alternative

Platforms like Klarity Health use a pay-per-appointment model — you pay a listing fee only when a pre-qualified patient books with you. No upfront marketing spend, no monthly subscriptions, no wasted ad dollars on clicks that don’t convert.

The value proposition:

• Pre-qualified patients already matched to your specialty and availability
• No upfront costs — you only pay when you see patients
• Built-in infrastructure — telehealth platform, scheduling, patient communication
• Both insurance and cash-pay patient flow
• You control your schedule — work as much or as little as you want

Frame it this way: instead of gambling $3,000-5,000/month on marketing with uncertain ROI, you pay only when a patient actually shows up for an appointment. That’s guaranteed ROI versus risky speculation.

For psychiatrists scaling up or entering telehealth, platforms remove the patient acquisition risk entirely while providing the infrastructure to practice efficiently.

Best Practices for Compliant Telehealth ADHD Prescribing

Given increased regulatory scrutiny (particularly after some telehealth platforms were investigated for over-prescribing stimulants with minimal oversight), adhering to best practices is essential:

Thorough Initial Evaluation

• Comprehensive psychiatric history: childhood symptoms, current presentation, functional impairment
• Use standardized rating scales: ADHD RS-IV, ASRS, Conners (depending on age)
• Rule out alternative diagnoses: anxiety, bipolar disorder, substance use that might mimic ADHD
• Obtain collateral information when possible (especially for children/adolescents — school records, parent/teacher reports)
• Document DSM-5 criteria explicitly in your note

Informed Consent

• Discuss risks of stimulant treatment: cardiovascular effects, potential for misuse/diversion, side effects
• Document consent for telehealth specifically (many states require this)
• Set expectations for monitoring, follow-up frequency, and prescription policies

Baseline Monitoring

• Obtain baseline vital signs (BP, HR) — coordinate with patient’s PCP if needed, or have patient self-report from pharmacy/home
• Screen for cardiac history or risk factors (family history of sudden cardiac death, structural heart disease)
• Consider baseline EKG in patients with cardiac concerns (not universally required but prudent in certain cases)

Prescription Monitoring Program (PDMP) Checks

• Check your state’s PDMP before prescribing — this is mandatory in many states (New York, Florida, etc.)
• Look for red flags: overlapping stimulant prescriptions, doctor shopping, concurrent benzodiazepines or opioids
• Document your PDMP check in the patient chart

Regular Follow-Ups

• Monthly visits initially (stimulants are typically dispensed in 30-day increments with no refills allowed on Schedule II)
• Monitor: symptom response, side effects, adherence, vital signs, functional improvement
• Adjust dose or medication as needed based on clinical response
• Consider less frequent follow-ups (every 2-3 months) once stable, but still check in regularly

Diversion Risk Mitigation

• Verify patient identity and location at each visit (especially important for controlled substances)
• Be alert to requests for early refills, dose escalations without clear clinical need, or refusal of alternative treatments
• Consider urine drug screens if concerned about diversion or co-occurring substance use
• Maintain clear boundaries: no early refills without documented emergency, no prescribing outside of scheduled appointments

Documentation Standards

• Justify every controlled prescription with documented symptoms, treatment plan, and response
• Use telehealth-specific documentation: note platform used, patient location, that visit met standard of care
• If your state requires it, document patient consent for telehealth at each encounter

These practices aren’t just about compliance — they’re about delivering high-quality care that stands up to scrutiny and keeps your license protected.

What Happens If the Federal Waiver Expires?

If the DEA’s telehealth flexibility ends without replacement, psychiatrists would need to conduct at least one in-person exam before prescribing Schedule II stimulants to new patients (per the Ryan Haight Act).

Practical workarounds:

1. Hybrid model: Partner with local clinics, urgent cares, or primary care practices to conduct brief in-person initial evaluations, then continue with telehealth for ongoing management
2. Start with non-stimulants: Begin treatment with Strattera, Qelbree, or other non-controlled medications via telehealth, then transition to stimulants after an in-person visit
3. Geographic focus: If you hold licenses in multiple states, prioritize states with in-person access points where you can arrange evaluations
4. Platform partnerships: Some telehealth companies are preparing networks of in-person evaluation sites — ask whether your platform has contingency plans

The good news: follow-up prescriptions don’t require in-person visits even under the Ryan Haight Act. Once you’ve established the patient with that initial in-person exam, you can manage them entirely via telehealth going forward.

And realistically, given the overwhelming demand for ADHD care and the success of telehealth treatment, there’s strong political momentum for Congress to permanently authorize telehealth controlled substance prescribing. But until that happens, prepare for both scenarios.

Why ADHD Telehealth Makes Sense for Psychiatrists in 2026

Let’s bring it all together:

Patient Demand is Massive

• Adult ADHD diagnoses surged during the pandemic and remain elevated
• Pediatric ADHD referrals often face 6-12 month waitlists in underserved areas
• Stimulant prescriptions increased substantially 2020-2023, even with supply constraints

Access Gaps Are Wide

• States like Texas and Florida have 1 psychiatrist per 8,000-9,000 residents
• Rural counties across all states face critical shortages
• Telehealth is often the only realistic option for patients in these areas

Economics Are Favorable

• Reimbursement parity means you’re paid the same for telehealth as in-person
• Low overhead (no office rent, minimal staff)
• Patient acquisition through platforms removes marketing risk and cost
• High patient volume potential (ADHD med checks are 15-30 minute appointments)

Regulatory Environment Is Supportive (For Now)

• Federal flexibilities remain through 2025, with extension likely
• Most states have removed telehealth barriers
• Reimbursement parity is locked in via state laws in nearly all markets

You Have Irreplaceable Authority

• Only psychiatrists can prescribe ADHD medications independently in every state
• NP restrictions in major states (Texas, Florida, Pennsylvania) create guaranteed demand for MDs
• Your license removes barriers that constrain other providers

Is Klarity Right for Your ADHD Practice?

If you’re a psychiatrist considering whether to join a telehealth platform for ADHD medication management, here’s the decision framework:

Klarity makes sense if:

• You want patient volume without the marketing investment and risk
• You prefer flexibility — work as much or little as you want, set your own schedule
• You’re comfortable with video-based evaluations and documentation (if you’re doing this already, no learning curve)
• You want to serve underserved populations without relocating to rural areas
• You value infrastructure support (telehealth platform, scheduling, patient communication handled)

Klarity may not be the best fit if:

• You already have a full in-person practice and aren’t looking to expand
• You prefer long-term psychotherapy relationships over focused medication management
• You want to build your own brand and patient panel (though you can do both — platforms supplement, not replace, independent practice)
• You’re uncomfortable with the pay-per-appointment model vs. traditional fee-for-service

The Questions to Ask:

1. What’s the patient volume commitment? Can I set my own schedule or are there minimum hour requirements?
2. How does credentialing work? Does Klarity handle insurance credentialing in-network or is this cash-pay/out-of-network?
3. What’s the per-appointment fee structure? How does it compare to my current net revenue per visit after overhead?
4. How are collaborative agreements handled if I want to work with NPs in restricted states?
5. What happens if federal telehealth rules change? Does Klarity have contingency plans for in-person evaluations?
6. What states am I licensed in, and which states does Klarity need providers in most? (focus on high-demand, underserved markets where your license maximizes patient access)

The Bottom Line for Psychiatrists

As of February 2026, you can absolutely prescribe ADHD medications via telehealth as a psychiatrist. The regulatory framework supports it (through at least the end of 2025 with high likelihood of extension), reimbursement is solid, patient demand is overwhelming, and the economics are favorable.

Your MD/DO license gives you advantages that other providers don’t have: no supervision requirements, no state-by-state prescribing restrictions, highest reimbursement rates, and the ability to prescribe any ADHD medication in any state where you’re licensed.

The uncertainty around federal telehealth policy is real, but it’s manageable with the right preparation. And the core value proposition — using technology to deliver high-quality psychiatric care to patients who desperately need it, while building a flexible, well-compensated practice — remains strong.

Whether you join a platform like Klarity or build your own telehealth practice, ADHD medication management via telemedicine is one of the most efficient, impactful ways to practice psychiatry in 2026.

Ready to explore expanding your ADHD practice via telehealth? Learn more about joining Klarity’s provider network and start connecting with patients who need your expertise.

Frequently Asked Questions

Can I prescribe Adderall to a new patient via telehealth right now?

Yes, as of February 2026, psychiatrists can prescribe Schedule II stimulants (Adderall, Vyvanse, Ritalin, etc.) to new patients via telehealth under the extended federal waiver. This flexibility runs through the end of 2025 and may be extended further or made permanent. You must conduct a proper audio-visual evaluation, document appropriately, and meet standard-of-care requirements.

Do I need an in-person visit before prescribing ADHD medications?

Not currently, under the federal telehealth waiver. However, this could change if the waiver expires without replacement legislation. Best practice: stay informed on DEA rulemaking, have contingency plans for in-person evaluations if required, and ensure your telehealth platform has protocols in place.

What states can I practice telehealth psychiatry in?

You can practice telehealth in any state where you hold a valid medical license. The patient must be physically located in a state where you’re licensed during the visit. Some states participate in the Interstate Medical Licensure Compact (IMLC), which streamlines the process of getting licensed in multiple states.

Is telehealth reimbursement the same as in-person for ADHD visits?

Yes, in nearly all cases. Approximately 48 states have telehealth payment parity laws or policies, and Medicare treats tele-mental health visits the same as in-person. You’ll bill the same CPT codes (99213, 99214, 90792) with a telehealth place-of-service code or modifier.

How do I check the prescription monitoring database for telehealth patients?

You access your state’s PDMP the same way you would for in-person patients — through the state’s online portal. Many states require PDMP checks before prescribing any Schedule II-IV controlled substances. Some telehealth platforms integrate PDMP access into their EHR systems for convenience.

Can I prescribe ADHD medications across state lines?

Only if you’re licensed in both the state where you’re located AND the state where the patient is located during the visit. You cannot practice medicine in a state where you’re not licensed, even via telehealth. Some platforms help arrange multi-state licensing for providers.

What’s the difference between psychiatrist and PMHNP prescribing authority for ADHD?

Psychiatrists (MD/DO) have full independent prescribing authority in all 50 states with no supervision required. PMHNPs face state-by-state restrictions: some states grant full independence (New York, Illinois after experience requirements), while others require physician collaboration (Florida, Pennsylvania) or prohibit NPs from prescribing Schedule II outpatient (Texas). For ADHD stimulant prescribing, psychiatrists have universal authority while NPs must navigate varying state laws.

How long does an ADHD evaluation take via telehealth?

Initial evaluations typically run 45-60 minutes (billed as 90792). Follow-up medication management visits are usually 15-30 minutes (99213 or 99214). Some psychiatrists do shorter focused visits for established patients who are stable on medication.

What happens if the patient is in a different state during their appointment?

The patient must be in a state where you hold an active medical license. If they travel, you either need to be licensed in that state or reschedule the appointment for when they return to a state where you’re licensed. This is a legal requirement, not just a best practice.

Do I need malpractice insurance that covers telehealth?

Yes. Most malpractice policies now include telehealth coverage, but verify with your carrier. If you’re working through a platform, ask whether they provide malpractice coverage or require you to carry your own.

Sources and Citations

The following sources were used to compile this article. All regulatory and scope-of-practice information has been verified against current official sources as of February 2026.

Federal Telehealth and DEA Regulations

• DEA/HHS Extension of COVID-Era Telehealth Flexibilities – Axios News, November 18, 2024 (axios.com) – Confirms extension of telehealth controlled substance prescribing through December 31, 2025 (third extension).

• Federal Telehealth Prescribing Policy Status – Axios News, September 18, 2024 (axios.com) – Analysis of pandemic-era waivers and potential congressional action on permanent telehealth prescribing authority.

State Telehealth Laws and Prescribing Authority

• Florida Statute §456.47 (Telehealth) – Florida Legislature (flsenate.gov) – Official state law defining exceptions for telehealth prescribing of Schedule II controlled substances for psychiatric disorders (current through 2023 session).

• Florida Statute §464.012 (APRN Prescribing) – Florida Legislature (leg.state.fl.us) – Official statute detailing NP scope of practice, 7-day Schedule II limit, and psychiatric nurse exception.

• Texas Telemedicine Standards (SB 1107 Analysis) – Texas Legislature, 88th Session (capitol.texas.gov) – Bill analysis documenting Texas telehealth standards and concerns about controlled substance prescribing (April 2023).

• Texas State Telehealth Laws – Center for Connected Health Policy (CCHP), updated January 19, 2026 (cchpca.org) – Comprehensive summary of Texas telehealth rules including restrictions on chronic pain treatment via telemedicine.

Nurse Practitioner Prescriptive Authority

• **

Source:

• https://www.axios.com/2024/09/18/telehealth-services-controlled-substances-congress#:~:text=Why%20it%20matters%3A%20Pandemic,end%20of%20this%20year%20after
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,the%20third%20temporary%20extension%20of
• https://www.flsenate.gov/Laws/Statutes/2023/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.flsenate.gov/Laws/Statutes/2023/456.47#:~:text=1,disorder
• https://rxagent.co/blog/np-prescribing-authority#:~:text=OK%20%20,day%20%28ongoing%29%20%5B3
• https://rxagent.co/blog/np-prescribing-authority#:~:text=TN%20%20,NP%3A%20Independent%20%5B3
• https://rxagent.co/blog/np-prescribing-authority#:~:text=match%20at%20L210%20NY%20,terminal%20illness%2C%20MD%20initiation
• https://rxagent.co/blog/np-prescribing-authority#:~:text=ID%20%20,3
• https://rxagent.co/blog/np-prescribing-authority#:~:text=FL%20%20,NP%3A%20Independent%20%5B3
• https://www.leg.state.fl.us/STATUTeS/index.cfm?Appmode=DisplayStatute&Search_String=&URL=0400-0499%2F0464%2FSections%2F0464.012.html#:~:text=also%20limit%20the%20prescribing%20of,shall%20adopt%20by%20rule%20the